Salmi-Smail et al., 2010 - Google Patents
Modified cap group suberoylanilide hydroxamic acid histone deacetylase inhibitor derivatives reveal improved selective antileukemic activitySalmi-Smail et al., 2010
View PDF- Document ID
- 8364549121280351216
- Author
- Salmi-Smail C
- Fabre A
- Dequiedt F
- Restouin A
- Castellano R
- Garbit S
- Roche P
- Morelli X
- Brunel J
- Collette Y
- Publication year
- Publication venue
- Journal of medicinal chemistry
External Links
Snippet
A series of SAHA cap derivatives was designed and prepared in good-to-excellent yields that varied from 49% to 95%. These derivatives were evaluated for their antiproliferative activity in several human cancer cell lines. Antiproliferative activity was observed for …
- 230000001976 improved 0 title abstract description 13
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Salmi-Smail et al. | Modified cap group suberoylanilide hydroxamic acid histone deacetylase inhibitor derivatives reveal improved selective antileukemic activity | |
| Cheng et al. | Discovery of potent and selective epidermal growth factor receptor (EGFR) bifunctional small-molecule degraders | |
| Marek et al. | Characterization of histone deacetylase 8 (HDAC8) selective inhibition reveals specific active site structural and functional determinants | |
| Ferraro et al. | Allosteric modulators of HSP90 and HSP70: dynamics meets function through structure-based drug design | |
| Heimburg et al. | Structure-based design and biological characterization of selective histone deacetylase 8 (HDAC8) inhibitors with anti-neuroblastoma activity | |
| Olson et al. | Discovery of the first histone deacetylase 6/8 dual inhibitors | |
| Heimburg et al. | Structure-based design and synthesis of novel inhibitors targeting HDAC8 from Schistosoma mansoni for the treatment of schistosomiasis | |
| Wagner et al. | Potent and selective inhibition of histone deacetylase 6 (HDAC6) does not require a surface-binding motif | |
| Thinon et al. | N-myristoyltransferase inhibition induces ER-stress, cell cycle arrest, and apoptosis in cancer cells | |
| Rodrigues et al. | Design, synthesis, and pharmacological evaluation of novel N-acylhydrazone derivatives as potent histone deacetylase 6/8 dual inhibitors | |
| Suzuki et al. | Rapid discovery of highly potent and selective inhibitors of histone deacetylase 8 using click chemistry to generate candidate libraries | |
| Simon et al. | KATching-up on small molecule modulators of lysine acetyltransferases | |
| Mishra et al. | The development of Hsp90β-selective inhibitors to overcome detriments associated with pan-Hsp90 inhibition | |
| Farooqi et al. | Novel lysine-based thioureas as mechanism-based inhibitors of sirtuin 2 (SIRT2) with anticancer activity in a colorectal cancer murine model | |
| Tanaka et al. | A practical use of ligand efficiency indices out of the fragment-based approach: ligand efficiency-guided lead identification of soluble epoxide hydrolase inhibitors | |
| Cao et al. | The process and strategy for developing selective histone deacetylase 3 inhibitors | |
| Suzuki et al. | Design, synthesis, and biological activity of boronic acid-based histone deacetylase inhibitors | |
| Li et al. | Biological evaluation of new largazole analogues: alteration of macrocyclic scaffold with click chemistry | |
| Hanafi et al. | Discovery of a Napabucasin PROTAC as an Effective Degrader of the E3 Ligase ZFP91 | |
| Mai et al. | Binding mode analysis of 3-(4-benzoyl-1-methyl-1 H-2-pyrrolyl)-N-hydroxy-2-propenamide: a new synthetic histone deacetylase inhibitor inducing histone hyperacetylation, growth inhibition, and terminal cell differentiation | |
| Huang et al. | Discovery of new SIRT2 inhibitors by utilizing a consensus docking/scoring strategy and structure–activity relationship analysis | |
| Poli et al. | Binding investigation and preliminary optimisation of the 3-amino-1, 2, 4-triazin-5 (2 H)-one core for the development of new Fyn inhibitors | |
| Martínez et al. | Multitarget anticancer agents based on histone deacetylase and protein kinase CK2 inhibitors | |
| Frühauf et al. | Non-hydroxamate zinc-binding groups as warheads for histone deacetylases | |
| Reddy et al. | Design and synthesis of simplified largazole analogues as isoform-selective human lysine deacetylase inhibitors |